1. Home
  2. TG vs OBIO Comparison

TG vs OBIO Comparison

Compare TG & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tredegar Corporation

TG

Tredegar Corporation

HOLD

Current Price

$8.32

Market Cap

273.5M

Sector

Industrials

ML Signal

HOLD

Logo Orchestra BioMed Holdings Inc.

OBIO

Orchestra BioMed Holdings Inc.

HOLD

Current Price

$4.32

Market Cap

246.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TG
OBIO
Founded
1988
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
273.5M
246.2M
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
TG
OBIO
Price
$8.32
$4.32
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$14.25
AVG Volume (30 Days)
120.7K
183.6K
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
151.06
33.13
EPS
0.96
N/A
Revenue
$800,821,000.00
$33,482,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$12.43
P/E Ratio
$8.53
N/A
Revenue Growth
8.29
1169.22
52 Week Low
$6.25
$2.20
52 Week High
$9.66
$5.42

Technical Indicators

Market Signals
Indicator
TG
OBIO
Relative Strength Index (RSI) 54.62 50.14
Support Level $7.52 $4.02
Resistance Level $9.26 $4.88
Average True Range (ATR) 0.29 0.26
MACD 0.10 -0.04
Stochastic Oscillator 91.85 41.77

Price Performance

Historical Comparison
TG
OBIO

About TG Tredegar Corporation

Tredegar Corp, through its subsidiaries, engages in the manufacture of polyethylene plastic films, polyester films, and aluminum extrusions. Polyethylene plastic films produce plastic films, elastics, and laminate materials that are used in personal care products, surface protection films, and specialty and optical lighting applications. The company operates through segments including PE films, flexible packaging films, and aluminum extrusions. Aluminum extrusions generate the majority of revenue and provide high-quality, soft-alloy, medium-strength aluminum utilized in the building and construction, automotive, consumer durables, machinery and equipment, electrical, and distribution markets. Revenue is generated from the United States, Asia, and Brazil.

About OBIO Orchestra BioMed Holdings Inc.

Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.

Share on Social Networks: